BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2010
View Archived Issues
BSAM-2/Alhydrogel/CPG-7909 vaccine enters clinical evaluation in malaria-naive adults
Read More
Phase I data support safety and preliminary activity of MLTA3698A in active RA
Read More
PET tracer [11C]-NS-14492 can visualize in vivo occupancy of nicotinic acetylcholine alpha7 receptor
Read More
Mitsubishi Tanabe Pharma reports highlights of second quarter fiscal year 2010
Read More
Roche reports on third quarter of 2010
Read More
FDA advisory committee recommends approval of Benlysta for SLE
Read More
Switch pocket kinase inhibitors DP-4610, DP-3556 and DP-4178 show promise in models of RA
Read More
Typhoid fever vaccine Vi-TT is safe in pediatric and juvenile subjects
Read More
Vectura presents phase II data on VR-040 in Parkinson's disease
Read More
New tyrosine protein kinase inhibitor-oligomer conjugates claimed
Read More
Allozyne reports proof-of-concept data on AZ-17
Read More
New inhibitors of alpha-amylase 1 and lysosomal alpha-glucosidase patented
Read More
Clinuvel receives Australian orphan drug status for Scenesse in EPP and CEP
Read More
New modulators of retinol-binding protein 4 presented by IRM
Read More
Takeda patents new modulators of retinol binding protein 4
Read More
Juvenile Diabetes Research Foundation and Amylin Pharma partner on metreleptin
Read More
Cardio3 BioSciences reports on phase II C-Cure trial in heart failure
Read More
Banyu Pharma describes new agonists of bile acid GPBA receptor
Read More
Anthera Pharma places voluntary hold on PEARL-SC trial
Read More
Orally disintegrating imidafenacin tablet approved in Japan for overactive bladder
Read More
EMA accepts Pixuvri MAA for non-Hodgkin's lymphoma for review
Read More
Intercell reports phase II data on V-710 vaccine in end-stage renal disease
Read More
FDA advisory committee recommends approval of Merck & Co.'s sBLA for Gardasil
Read More
Encouraging interim data reported from phase IIb TMC-435 trial in hepatitis C
Read More
EMA's COMP recommends orphan status for paquinimod in systemic sclerosis
Read More